Episode 6 - Expert-Guided Strategies to Improve Recognition, Diagnosis, and Treatment of PH Associated with ILD - Part 3: Case Studies to Incorporate Evidence Into Practice

Pulmonary hypertension among patients with interstitial lung diseases (PH-ILD) is currently under-recognized and is associated with increased morbidity, mortality, and healthcare burden. Individualized treatment approaches need to be incorporated in the continuum of care to improve early detection, accurate diagnosis, and improved patient outcomes. In this podcast series, Drs. Jean Elwing, Steven Nathan, and Ioana Preston inform and guide on recent insights to screen for, detect, and accurately diagnose PH-ILD. This on-demand audio presentation uses didactic, case-based, and conversational formats to provide practical guidance and increase familiarity with the latest best-practice approaches for treatment and management of PH-ILD, to ultimately improve the quality of life of patients.Launch Date: October 14, 2024Release Date: October 7, 2024Expiration Date: September 30, 2025FACULTYSteven Nathan, MDMedical Director, Advanced Lung Disease and Transplant ProgramInova Fairfax HospitalJean Elwing, MDProfessor of MedicineDirector, Pulmonary Hypertension ProgramUniversity of CincinnatiIoana Preston, MDAssociate Professor of MedicineTufts University School of MedicineThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/expert-guided-strategies-to-improve-recognition-diagnosis-and-treatment-of-ph-associated-with-ild-1